Alnylam Pharmaceuticals, Inc. (ALNY)
412.88
+8.42
(+2.08%)
USD |
NASDAQ |
Dec 11, 16:00
412.88
0.00 (0.00%)
After-Hours: 18:44
Alnylam Pharmaceuticals Research and Development Expense (TTM): 1.248B for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Pfizer Inc. | 10.13B |
| Glaukos Corp. | 143.49M |
| Bristol Myers Squibb Co. | 9.719B |
| BridgeBio Pharma, Inc. | 465.89M |
| Vertex Pharmaceuticals, Inc. | 3.954B |